Related Experiment Videos
Clinical trial design and end points for epidermal growth factor receptor-targeted therapies: implications for drug
Carlos L Arteaga1, Jose Baselga
1Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6307, USA. carlos.arteaga@vanderbilt.edu
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
ERK1/2 Inhibitor Ulixertinib in Pan-cancer Patients with BRAF Fusions or Non-V600E/K Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1L.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
KRAS Q61 NSCLC: When Alleles Matter.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Target Antigen Identification for Antibody Drug Conjugate Therapy in Biliary Tract Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Response-Adapted Surgery after Neoadjuvant Immunochemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma (REMATCH): A Single-Arm Phase II Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Associations of Baseline Neutrophil-to-Lymphocyte Ratio with Efficacy and Toxicity of the B7H3 ADC YL201, Linked to Interleukin-6: Analysis of the Phase 1/1b Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Ceralasertib plus durvalumab in Ras mutant and Ras wild type advanced non-small cell lung cancer: Two cohorts of the phase II platform National Lung Matrix Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Neoadjuvant Pertuzumab Biosimilar HLX11 Versus Reference Pertuzumab for Early-stage or Locally Advanced Breast Cancer: A phase 3 Equivalence Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Remodeling the tumor immune microenvironment: mechanisms of crosstalk between regulated cell death macrophages.
Frontiers in immunology·2026
Pathological role of deubiquitinating enzymes in lung cancer: recent insights and advances.
American journal of cancer research·2026